Skip to main content
. 2022 Sep 14;37(11):2301–2307. doi: 10.1002/mds.29220

FIG 1.

FIG 1

Axial images presenting group averages for [11C]3‐amino‐4‐(2‐dimethylaminomethyl‐phenylsulfaryl)‐benzonitrile (DASB) positron emission tomography in patients with MSA and PD. White arrows in the top rows show reduced [11C]DASB binding in MSA compared with PD in several ROIs. MSA, multiple system atrophy; PD, Parkinson's disease; ROI, region of interest.